RINALDI, Vittorio Mario
 Distribuzione geografica
Continente #
NA - Nord America 1.298
EU - Europa 280
AS - Asia 130
AF - Africa 29
SA - Sud America 8
OC - Oceania 3
Totale 1.748
Nazione #
US - Stati Uniti d'America 1.290
UA - Ucraina 88
SE - Svezia 63
IT - Italia 58
IN - India 55
SG - Singapore 49
FI - Finlandia 27
TG - Togo 25
CN - Cina 24
DE - Germania 19
GB - Regno Unito 16
AR - Argentina 6
IE - Irlanda 6
BZ - Belize 4
CA - Canada 4
BJ - Benin 3
NZ - Nuova Zelanda 3
CL - Cile 2
JP - Giappone 2
RU - Federazione Russa 2
NL - Olanda 1
SC - Seychelles 1
Totale 1.748
Città #
Fairfield 203
Woodbridge 184
Chandler 90
Houston 82
Ashburn 78
Seattle 71
Cambridge 67
Wilmington 67
Ann Arbor 50
San Paolo di Civitate 39
Jacksonville 34
Singapore 34
Princeton 27
Plano 26
Lomé 25
Millbury 24
Lawrence 20
Beijing 19
Boardman 16
Rome 15
Des Moines 13
Dearborn 11
Falls Church 8
Norwalk 8
Andover 7
San Diego 7
San Mateo 7
Boston 6
Bremen 6
Dublin 6
Federal 6
Fremont 6
Santa Clara 5
Belize City 4
Toronto 4
Auckland 3
Bühl 3
Fasano 3
Frankfurt am Main 3
Los Angeles 3
Mannheim 3
Nanjing 2
Philadelphia 2
Saint Louis 2
Tokyo 2
Ahmedabad 1
Auburn Hills 1
Changsha 1
Columbus 1
Dallas 1
Falkenstein 1
Helsinki 1
Indiana 1
Jinan 1
Leawood 1
London 1
Mahé 1
Mumbai 1
Ningbo 1
San Jose 1
Southend 1
Tappahannock 1
Wandsworth 1
Totale 1.319
Nome #
A new highly effective short-term therapy schedule for Helicobacter pylori eradication. 102
Relationship between antral lymphocyte density and basal gastrin levels in patients with Helicobacter pylori infection. 96
Helicobacter pylori urease inhibition and ammonia levels in cirrhotic patients 88
Omeprazole plus clarithromycin and either tinidazole or tetracycline for Helicobacter pylori infection: A randomized prospective study 87
The management of failed dual or triple therapy for Helicobacter pylori eradication 87
Zinc, ammonia, and Helicobacter pylori infection in liver cirrhosis. 84
Reflux oesophagitis after Helicobacter pylori treatment 80
Helicobacter pylori eradication with proton pump inhibitor – based triple therapies and re – treatment with ranitidine bismuth citrate – based triple therapy 78
Progression of low risk esophageal varices in cirrhotic patients 78
Natural history of low risk esophageal varices in cirrhotic patients 76
A new 10-day regimen for Helicobacter pylori (HP) eradication 68
Helicobacter pylori diagnosis in patients with liver cirrhosis 68
Gastric pathology in cholecystectomy patients: Role of Helicobacter pylori and bile reflux 67
Factors predicting the presence of esophageal varices in compensated cirrhotic patients 66
Clinical and histologic predictors of Helicobacter pylori infection recurrence 64
Ascorbic acid and intestinal metaplasia in the stomach: a prospective, randomized study 62
Gastric epithelial cell proliferation in patients with liver cirrhosis 61
Duodenal stenosis may not regress after eradication of Helicobacter pylori 60
Incidence and natural history of small esophageal varices in cirrhotic patients 58
Helicobacter pylori eradication with dual and low-dose triple therapy in patients with liver cirrhosis 55
Helicobacter pylori and plasma ammonia levels in cirrhotics: role of urease inhibition by acetohydroxamic acid 55
Helicobacter pylori infection in dyspeptic cirrhotic patients 53
Reflux oesophagitis after Helicobacter pylori treatment. 53
Helicobacter pylori infection, plasma ammonia levels, and psychometric testing in cirrhotic patients 51
Lansoprazole/amoxicillin versus omeprazole/amoxicillin in Helicobacter pylori eradication 32
Omeprazole plus clarithromycin and either tinidazole or tetracycline for Helicobacter pylori treatment 31
Totale 1.760
Categoria #
all - tutte 4.233
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.233


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020338 0 0 0 24 39 70 48 53 45 29 19 11
2020/2021108 14 24 3 9 1 12 0 15 9 11 6 4
2021/2022277 1 20 29 6 46 10 5 33 21 26 25 55
2022/2023361 45 98 13 46 45 51 1 14 29 8 11 0
2023/202485 8 22 8 9 1 0 1 5 0 17 8 6
2024/202538 19 2 17 0 0 0 0 0 0 0 0 0
Totale 1.760